U.S. FDA approves Portola blood-thinner to prevent blood clots

(Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc. to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.